---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-038240"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2026-08-14T19:00:21+00:00"
generated_at: "2026-08-14T19:02:08.258374+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics non-reliance on Q1 2026 financials; EPS overstated by $0.80

## Summary
- Audit Committee concluded Aug 10, 2026 that Q1 2026 financials in Form 10-Q (filed May 14, 2026) should no longer be relied upon.
- EPS overstated by $0.80: reported $2.19 basic/diluted; correct two-class allocation is 63.3% to common, 36.7% to participating securities.
- As of Mar 31, 2026: 904,312 weighted-average common shares; 524,501 shares from participating warrants outstanding.
- Material weakness in internal control over financial reporting: ineffective technical accounting review of complex warrant instruments.
- Company will file Form 10-Q/A and amend registration statements; remediation measures include enhanced technical accounting review.

## SEC filing metadata
- accession: 0001493152-26-038240
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2026-08-14T19:00:21+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000149315226038240/0001493152-26-038240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226038240/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-038240
- JSON: https://secwatch.observer/filing/0001493152-26-038240.json
- Plain text: https://secwatch.observer/filing/0001493152-26-038240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.